Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Chloroquine
Drug ID BADD_D00440
Description Chloroquine is an aminoquinolone derivative first developed in the 1940s for the treatment of malaria.[A191655] It was the drug of choice to treat malaria until the development of newer antimalarials such as [pyrimethamine], [artemisinin], and [mefloquine].[A191787] Chloroquine and its derivative [hydroxychloroquine] have since been repurposed for the treatment of a number of other conditions including HIV, systemic lupus erythematosus, and rheumatoid arthritis.[A192432] **The FDA emergency use authorization for [hydroxychloroquine] and chloroquine in the treatment of COVID-19 was revoked on 15 June 2020.[L14312]** Chloroquine was granted FDA Approval on 31 October 1949.[L12054]
Indications and Usage Chloroquine is indicated to treat infections of _P. vivax_, _P. malariae_, _P. ovale_, and susceptible strains of _P. falciparum_.[L12051] It is also used to treat extraintestinal amebiasis.[L12051] Chloroquine is also used off label for the treatment of rheumatic diseases,[A191655] as well as treatment and prophylaxis of Zika virus.[A191649,A191652] Chloroquine is currently undergoing clinical trials for the treatment of COVID-19.[A191631]
Marketing Status approved; investigational; vet_approved
ATC Code P01BA01
DrugBank ID DB00608
KEGG ID D02366
MeSH ID D002738
PubChem ID 2719
TTD Drug ID D09EGZ
NDC Product Code Not Available
UNII 886U3H6UFF
Synonyms Chloroquine | Chlorochin | Chingamin | Khingamin | Nivaquine | Chloroquine Sulfate | Sulfate, Chloroquine | Chloroquine Sulphate | Sulphate, Chloroquine | Aralen | Arequin | Arechine
Chemical Information
Molecular Formula C18H26ClN3
CAS Registry Number 54-05-7
SMILES CCN(CC)CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Lethargy19.04.04.004; 17.02.04.003; 08.01.01.008--
Lichen planus23.03.08.001--Not Available
Logorrhoea17.02.08.006; 19.19.02.0010.000142%Not Available
Loss of consciousness17.02.04.0040.000213%Not Available
Macular degeneration06.09.03.001--Not Available
Maculopathy06.09.03.0070.000142%Not Available
Mania19.16.02.0020.000213%
Methaemoglobinaemia01.05.01.0020.000496%
Muscle atrophy17.05.03.004; 15.05.03.0030.000142%Not Available
Muscular weakness17.05.03.005; 15.05.06.0010.000142%
Myocardial infarction24.04.04.009; 02.02.02.0070.000142%
Myopathy15.05.05.001--Not Available
Nausea07.01.07.001--
Nephropathy20.05.03.0010.000142%Not Available
Neuromyopathy17.05.03.003; 15.05.03.010--Not Available
Neutropenia01.02.03.004--Not Available
Night blindness06.02.10.010; 14.12.03.001--
Optic atrophy06.09.02.0010.000213%Not Available
Pancytopenia01.03.03.003--Not Available
Personality change17.02.05.019; 19.05.01.006--
Photosensitivity reaction23.03.09.003--
Pleural effusion22.05.02.0020.000213%
Polyneuropathy17.09.03.012--Not Available
Protrusion tongue17.02.05.037; 07.14.02.002--Not Available
Pruritus23.03.12.001--
Psychomotor hyperactivity17.01.02.011; 19.11.02.0030.000142%Not Available
Pyrexia08.05.02.0030.000142%
Rash23.03.13.001--Not Available
Renal failure20.01.03.0050.000283%Not Available
Restrictive cardiomyopathy02.04.01.0050.000567%
The 3th Page    First    Pre   3 4 5    Next   Last    Total 5 Pages